ASTRAZENECA PLC (AZN)
A+
Pipeline Grade
Drug Pipeline (37 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
SELUMETINIB SULFATE
KOSELUGO |
APPROVED | — |
|
BUDESONIDE, FORMOTEROL FUMARATE
SYMBICORT AEROSPHERE |
APPROVED | — |
|
ALBUTEROL SULFATE, BUDESONIDE
AIRSUPRA |
APPROVED | — |
|
ANASTROZOLE
ARIMIDEX |
APPROVED | — |
|
FORMOTEROL FUMARATE, GLYCOPYRROLATE
BEVESPI AEROSPHERE |
APPROVED | — |
|
OSIMERTINIB MESYLATE
TAGRISSO |
APPROVED | — |
|
CAPIVASERTIB
TRUQAP |
APPROVED | — |
|
SELUMETINIB
KOSELUGO |
APPROVED | — |
|
BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE
SYMBICORT |
APPROVED | — |
|
SODIUM ZIRCONIUM CYCLOSILICATE
LOKELMA |
APPROVED | — |
|
ACALABRUTINIB
CALQUENCE |
APPROVED | — |
|
ACALABRUTINIB MALEATE
CALQUENCE |
APPROVED | — |
|
OMEPRAZOLE MAGNESIUM
PRILOSEC OTC |
NDA | — |
|
GEFITINIB
IRESSA |
NDA | — |
|
PRILOCAINE HYDROCHLORIDE
CITANEST |
NDA | — |
|
FELODIPINE
PLENDIL |
NDA | — |
|
EPINEPHRINE BITARTRATE, PRILOCAINE HYDROCHLORIDE
CITANEST FORTE |
NDA | — |
|
ENALAPRIL MALEATE, FELODIPINE
LEXXEL |
NDA | — |
|
VITAMIN A
AQUASOL A |
NDA | — |
|
OLAPARIB
LYNPARZA |
NDA | — |
|
DYCLONINE HYDROCHLORIDE
DYCLONE |
NDA | — |
|
LIDOCAINE, PRILOCAINE
EMLA |
NDA | — |
|
BUDESONIDE
RHINOCORT |
NDA | — |
|
DEZOCINE
DALGAN |
NDA | — |
|
METAPROTERENOL SULFATE
METAPROTERENOL SULFATE |
NDA | 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),, 2 Years PSA Recurrence Rate, Abdominal Aortic Aneurysm, Absorption, Acid Reflux Disease, Acid Regurgitation, Active Systemic Lupus Erythematosus, Acute, Acute Bipolar Depression, Acute Bipolar Mania, Acute Bipolar Manic Episode, Acute Coronary Syndrom, Acute Coronary Syndrome, Acute Coronary Syndrome (ACS), Acute Coronary Syndrome, Old Myocardial Infarction, Acute Coronary Syndromes, Acute Decompensated Heart Failure, Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Acute Exacerbations of COPD, Acute Ischaemic Stroke, Acute Kidney Injury, Acute Liver Injury, Acute Lymphoblastic Leukaemia, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Recurrent, Acute Lymphoblastic Leukemia, Adult, Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Pediatric, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukaemia, Acute Myeloid Leukemia, Acute Myocardial Infarction, Acute Psychotic Sympto |
|
FUROSEMIDE
FUROSEMIDE |
NDA | — |
|
ETIDOCAINE HYDROCHLORIDE
DURANEST |
NDA | — |
|
EPINEPHRINE, ETIDOCAINE HYDROCHLORIDE
DURANEST |
NDA | — |
|
EPINEPHRINE BITARTRATE, ETIDOCAINE HYDROCHLORIDE
DURANEST |
NDA | — |
|
ISOETHARINE HYDROCHLORIDE
ISOETHARINE HYDROCHLORIDE |
NDA | — |
|
TOCAINIDE HYDROCHLORIDE
TONOCARD |
NDA | — |
|
ESOMEPRAZOLE SODIUM
NEXIUM IV |
NDA | — |
|
DROPERIDOL, FENTANYL CITRATE
FENTANYL CITRATE AND DROPERIDOL |
NDA | — |
|
RITODRINE HYDROCHLORIDE
YUTOPAR |
NDA | — |
|
TAMOXIFEN CITRATE
NOLVADEX |
NDA | — |
|
DROPERIDOL
DROPERIDOL |
NDA | — |
|
OMEGA-3-CARBOXYLIC ACIDS
EPANOVA |
NDA | — |
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (4)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06465810 | Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis | OTHER | Recruiting | 1,850 |
| NCT07205666 | The Eplontersen Pregnancy and Lactation Outcomes Study | OTHER | Recruiting | 10 |
| NCT06981169 | PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and A... | OTHER | Recruiting | 1,500 |
| NCT07430306 | A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve S... | PHASE3 | Recruiting | 245 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.